ExecPay

Henry J. Fuchs

Overview2021202020192018201720162015201420132012201120102009

2013

In 2013, Henry J. Fuchs earned a total compensation of $4.8M as Executive Vice President Chief Medical Officer at BioMarin Pharmaceutical, a 75% increase compared to previous year.

Compensation breakdown

Bonus$137,500
Non-Equity Incentive Plan$299,895
Option Awards$2,827,370
Salary$494,383
Stock Awards$1,057,836
Other$8,488
Total$4,825,472

Fuchs received $2.8M in option awards, accounting for 59% of the total pay in 2013.

Fuchs also received $137.5K in bonus, $299.9K in non-equity incentive plan, $494.4K in salary, $1.1M in stock awards and $8.5K in other compensation.

Rankings

In 2013, Henry J. Fuchs' compensation ranked 1,344th out of 12,286 executives tracked by ExecPay. In other words, Fuchs earned more than 89.1% of executives.

ClassificationRankingPercentile
All
1,344
out of 12,286		89th
Division
Manufacturing
432
out of 4,612		91st
Major group
Chemicals And Allied Products
117
out of 1,462		92nd
Industry group
Drugs
77
out of 1,156		93rd
Industry
Pharmaceutical Preparations
68
out of 890		92nd
Source: SEC filing on April 25, 2016.
20142012

Fuchs' colleagues

We found five more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2013.

2013

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

$11.4M

2013

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

$4M

2013

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

$3.6M

2013

G Davis

BioMarin Pharmaceutical

General Counsel

$2.7M

2013

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

$2.7M

News

In-depth

You may also like

Henry J. Fuchs
BioMarin Pharmaceutical
2013 ranking